Raymond James Financial »

Denali Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $368k 25k 14.52
2025-06-30 $372k 27k 13.99
2025-03-31 $353k 26k 13.59
2024-12-31 $533k 26k 20.38